To see the usefulness of the newly formed repertory formed by Dr. Rupal Bhatt based on H. C. AllenS keynotes and characteristic for the cases of Benign prostatic hyperplasia

Clinical Usefulness of rubrics related to Benign Prostatic Hyperplasia from Repertory Based on H. C. Allens Keynotes and Characteristics formed by Dr. Rupal Bhatt: An interventional uncontrolled clinical trial - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084007

Enrollment

Registered

2025-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N40- Benign prostatic hyperplasia

Interventions

Intervention1: Homoeopathic medicine after repertorization from repertory: Homoeopathic medicine after repertorization from repertory, Twice a day in 6C, 30C, 200C and 1M potency as need of the case,

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pre Diagnosed cases of Benign prostatic hyperplasia 2. Patients Between 45 years to 80 years of age

Exclusion criteria

Exclusion criteria: 1. Cases that need emergency treatment will be excluded. 2. Cases with PSA level above 10ng/mL as it is strongly suggestive of Malignancy of prostate.

Design outcomes

Primary

Measure	Time frame
IPSS SCCORE, USG ABDOMEN (IF REQUIRED)Timepoint: At the baseline and on each follow-up	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Atminkumar Limbachiya

Dr. V H Dave Homoeopathic Medical College & Smt. S I Patel (I) Homoeopathic Hospital , Anand

dr.meerashah@yahoo.com9898692003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026